SAN DIEGO, Dec. 4, 2017 /PRNewswire/ — Tioga Pharmaceuticals, Inc. announced today that its selective oral kappa opioid receptor agonist, asimadoline, significantly reduced nighttime itching and improved disease-related quality of life in a randomized, placebo-controlled, double blind…
